Jian-Feng Zhou Selected Research

Jian-Feng Zhou Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 03/2001
10	Leukemia 08/2014 - 10/2004
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2015 - 12/2012
4	Carcinoma (Carcinomatosis) 01/2016 - 10/2003
3	Hematologic Neoplasms (Hematological Malignancy) 10/2020 - 11/2011
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2011 - 02/2006
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2019 - 06/2008
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 09/2005
2	Infections 07/2010 - 09/2005
2	Breast Neoplasms (Breast Cancer) 02/2009 - 01/2005
1	Cerebral Hemorrhage 01/2022
1	Thrombotic Microangiopathies 11/2021
1	Aortic Dissection 11/2021
1	Hemorrhage 11/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 11/2021
1	Thrombotic Thrombocytopenic Purpura 11/2021
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 10/2021
1	Multiple Myeloma 06/2021
1	Exanthema (Rash) 01/2021
1	Esophageal Squamous Cell Carcinoma 01/2021
1	Anemia 01/2021
1	Asthenia 01/2021
1	Diarrhea 01/2021
1	Fatigue 01/2021
1	Heart Failure 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Vomiting 01/2021
1	Acute Promyelocytic Leukemia 01/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2019
1	Cardiotoxicity 06/2019
1	Primitive Neuroectodermal Tumors (PNET) 11/2018
1	Neutropenia 11/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2018
1	Lymphoma (Lymphomas) 10/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2017
1	Adenocarcinoma 08/2017
1	Disease Progression 08/2014
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2013
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 06/2013

Drug/Important Bio-Agent (IBA)

5	Messenger RNA (mRNA)IBA 07/2010 - 10/2003
4	Proteins (Proteins, Gene)FDA Link 07/2010 - 02/2006
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2013 - 12/2012
3	trichostatin A (A 300)IBA 02/2009 - 10/2005
2	Chimeric Antigen ReceptorsIBA 06/2021 - 12/2019
2	Dacarbazine (DIC)FDA LinkGeneric 01/2021 - 11/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 06/2019
2	Pharmaceutical PreparationsIBA 01/2021 - 06/2019
2	endostar proteinIBA 11/2018 - 12/2011
2	DNA (Deoxyribonucleic Acid)IBA 06/2015 - 06/2013
2	Biological ProductsIBA 08/2014 - 08/2014
2	Itraconazole (Sporanox)FDA LinkGeneric 11/2011 - 06/2006
2	AntigensIBA 02/2009 - 06/2008
2	Amphotericin B (Amphotericin)FDA LinkGeneric 09/2008 - 06/2006
2	Histone Deacetylase InhibitorsIBA 08/2006 - 10/2005
2	Histone Deacetylases (Histone Deacetylase)IBA 08/2006 - 10/2005
2	theasinensin AIBA 08/2006 - 10/2005
2	Butyric Acid (Butanoic Acid)IBA 01/2005 - 09/2003
1	thiamine triphosphorate (TTP)IBA 11/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 06/2021
1	B-Cell Maturation AntigenIBA 06/2021
1	Arsenic Trioxide (Trisenox)FDA Link 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2020
1	Methotrexate (Mexate)FDA LinkGeneric 10/2020
1	thymoglobulin FDA Link 10/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2020
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2020
1	Epirubicin (Ellence)FDA LinkGeneric 06/2019
1	AnthracyclinesIBA 06/2019
1	Tyrosine Kinase InhibitorsIBA 04/2019
1	Fluorouracil (Carac)FDA LinkGeneric 11/2018
1	Temozolomide (Temodar)FDA LinkGeneric 11/2018
1	AntibodiesIBA 10/2018
1	Histones (Histone)IBA 01/2018
1	MethyltransferasesIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	EnzymesIBA 01/2018
1	PlatinumIBA 01/2018
1	ChromatinIBA 01/2018
1	Gemcitabine FDA Link 08/2017
1	RNA Helicases (RNA Helicase)IBA 09/2015
1	TransferasesIBA 06/2015
1	Ikaros Transcription FactorIBA 08/2014
1	Sirtuin 1IBA 06/2014
1	VaccinesIBA 10/2013
1	Protein Subunit VaccinesIBA 10/2013
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 06/2013
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2013

Therapy/Procedure

12	Therapeutics 01/2022 - 03/2001
9	Drug Therapy (Chemotherapy) 01/2021 - 06/2006
3	Transplantation 10/2021 - 06/2013
1	Chemoradiotherapy 01/2022
1	Neoadjuvant Therapy 01/2022
1	Hematopoietic Stem Cell Transplantation 10/2021
1	Immunotherapy 01/2021